KAPPER MED
ActiveSummary
KAPPER MED has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2,283 and a net result of €1,452. Equity is shrinking by about 27% per year across the filed financial years. Its solvency ranks better than 89% of 5,571 sector peers (NACE 96, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 31 days late
2025
31-12
Financial
Back to profitnet €1,452
Net result €1,452 after 2 loss-making years.
30-09
NBB filing
Annual accounts filed
financial year 2024 · micro format · 61 days late
2024
31-12
Financial
Weakest financial yearnet -€2,697
Net result drops to -€2,697, the lowest in the series; recovery starts the following year.
02-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.